David Zawitz's most recent trade in Verrica Pharmaceuticals Inc was a trade of 10,000 Common Stock done at an average price of $4.2 . Disclosure was reported to the exchange on Nov. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verrica Pharma Inc | David Zawitz | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 25 Nov 2025 | 10,000 | 21,000 (0%) | 0% | 4.2 | 42,425 | Common Stock |
| Verrica Pharma Inc | David Zawitz | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2025 | 2,500 | 2,500 | - | - | Series C Warrant (right to buy) | |
| Verrica Pharma Inc | David Zawitz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 950,000 | 950,000 | - | - | Employee Stock Option (right to buy) |